Yi-pin Lv
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- IL-33, ST2, and ILC Pathways
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 16
- Immune Cell Function and Interaction 6
- Galectins and Cancer Biology 5
- IL-33, ST2, and ILC Pathways 3
- Mast cells and histamine 3
- Immune cells in cancer 2
- Surgery 12
- Helicobacter pylori-related gastroenterology studies 9
- Eosinophilic Esophagitis 4
- Co-authors
- Yong‐sheng Teng (20 shared papers)Yuan Zhuang (20 shared papers)Weisan Chen (18 shared papers)Ping Cheng (18 shared papers)Liu‐sheng Peng (16 shared papers)Quanming Zou (15 shared papers)Fangyuan Mao (16 shared papers)Yongliang Zhao (12 shared papers)
- Journals
- Cell Death and Disease (5 papers)Journal for ImmunoTherapy of Cancer (2 papers)Forests (1 paper)Advanced Healthcare Materials (1 paper)Cell Communication and Signaling (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Yi-pin Lv
26 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 84
- Immunology 742
- Oncology 476
- Cancer Research 106
- Surgery 184
- Gastroenterology 21
Countries citing papers authored by Yi-pin Lv
This map shows the geographic impact of Yi-pin Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-pin Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-pin Lv more than expected).
Fields of papers citing papers by Yi-pin Lv
This network shows the impact of papers produced by Yi-pin Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-pin Lv. The network helps show where Yi-pin Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi-pin Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 399 | |
| 2 | 2017 | 146 | |
| 3 | 2019 | 133 | |
| 4 | 2018 | 99 | |
| 5 | 2019 | 59 | |
| 6 | 2018 | 41 | |
| 7 | 2017 | 41 | |
| 8 | 2016 | 41 | |
| 9 | 2023 | 38 | |
| 10 | 2018 | 36 | |
| 11 | 2022 | 31 | |
| 12 | 2022 | 31 | |
| 13 | 2020 | 28 | |
| 14 | 2017 | 23 | |
| 15 | 2020 | 23 | |
| 16 | 2020 | 20 | |
| 17 | 2020 | 16 | |
| 18 | 2019 | 16 | |
| 19 | 2019 | 12 | |
| 20 | 2021 | 12 |
About Yi-pin Lv
Yi-pin Lv is a scholar working on Immunology, Surgery, Oncology, Molecular Biology and Rheumatology, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (9 papers), Immune Cell Function and Interaction (6 papers), Galectins and Cancer Biology (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Eosinophilic Esophagitis (4 papers), IL-33, ST2, and ILC Pathways (3 papers), Mast cells and histamine (3 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Immunology (742 citations), Oncology (476 citations), Cancer Research (106 citations), Surgery (184 citations) and Gastroenterology (21 citations). Yi-pin Lv has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Yong‐sheng Teng, Yuan Zhuang, Weisan Chen, Ping Cheng, Liu‐sheng Peng, Quanming Zou, Fangyuan Mao, Yongliang Zhao, Jinyu Zhang and Na Chen. Their work appears in journals such as Cell Death and Disease, Journal for ImmunoTherapy of Cancer, Forests, Advanced Healthcare Materials and Cell Communication and Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.